October 2023 - Page 4 of 8 - NetworkNewsWire

ThursdayOct 19, 2023 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Raised $1.6 Million in Latest Investment Round; Looks to Advance DehydraTECH(TM) Research Operations

Lexaria, a global innovator in drug delivery platforms, recently announced that it had entered into a securities purchase agreement with a single health-focused institutional investor The agreement is for the purchase of 1,618,330 shares of common stock at $0.97 per share, with gross proceeds amounting to approximately $1.6 million The raised funds will be integral to Lexaria advancing its operations, inching it closer to FDA approval for its patented DehydraTECH(TM)-processed CBD for the potential treatment of hypertension It will also help assert Lexaria’s position as a leader in the market, even as it pushes the envelope in terms of research…

ThursdayOct 19, 2023 9:00 am

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Advances Exploration Efforts in Brazilian REE Project Site

Canadian mineral explorer Appia Rare Earths & Uranium is acquiring project sites with rare earth element (“REE”) potential to help sustain American hemisphere independence in the REE supply chain The People’s Republic of China currently enjoys a near-monopoly over REE mining and production, leading Western nations to seek greater security for the metallic elements vital to modern computer technologies and the strong magnets used in them Appia recently reported updated results from its drilling programs designed to identify the extent of REE mineralization at the company’s project site in central Brazil, expressing excitement over the project’s potential The company is…

WednesdayOct 18, 2023 10:30 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Sees Ongoing Traction in Customer Demonstrations; Nears Proof-of-Concept for New Technology Offering

Hillcrest Energy recently provided investors with an update on the company’s commercial endeavors Hillcrest successfully completed dynamic load bench demonstrations of its SiC traction inverter with two potential e-mobility customers The news comes alongside the company’s growing customer traction, with Hillcrest announcing that it is simultaneously progressing through demonstration and co-development programs with 6 potential e-mobility customers On the product front, Hillcrest revealed it is nearing the proof-of-concept stage for its upcoming grid-connect inverter, with the technology expected to be unveiled prior to year end Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean technology company focused on developing transformative…

WednesdayOct 18, 2023 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Takes Aim at Supply Chain Threats with Strategy to Bolster American Production of Tech-essential REEs

Strategic metals supply chain enterprise Ucore Rare Metals Inc. has developed its own proprietary solution for separating rare earth elements from their host ores in hopes of re-establishing a North American base for the REE supply chain During an era of international trade tensions over computer tech asset sourcing, Ucore aims to reduce Americans’ reliance on China for the REEs critical to modern technology ranging from cell phones and computers to electric vehicle batteries Ucore’s RapidSX(TM) REE processing solution is being demonstrated as advantageous over industry-standard CSX processes in side-by-side testing at Ucore’s facility in Ontario, Canada Ucore is preparing…

WednesdayOct 18, 2023 9:00 am

Jewelry Maker GEMXX Corp. (GEMZ) Notes Growing Success in Quarterly Financial Statement

Las Vegas-based jewelry maker GEMXX Corporation is reporting positive net revenues, and $0.00 in long-term liabilities, in the company’s recently released quarterly financial statement GEMXX is unique in that it mines its own gold resources and is making plans to operate the world’s largest Ammolite gemstone mine soon, all for its distinctively iridescent jewelry products Ammolite is a gemstone derived from the fossilized shells of large, extinct marine nautiluses — commercially mined in Alberta, Canada, and nowhere else in the world The company has a fully qualified Tier 1, Form 1A registration to raise up to $6 million through its…

TuesdayOct 17, 2023 10:30 am

Octane’s Medical Innovation Forum 2023: Shaping the Future of Healthcare through Entrepreneurial Intelligence

Industry experts, entrepreneurs, investors, and innovators from all areas of the medical industry are invited to attend the Octanes Medical Innovation Forum 2023 being held October 25-26, 2023, at the Irvine Marriott, Irvine, California. The two-day event is set to present a convergence of revolutionary technologies, advanced ideas, and the best industry expertise. Leveraging the transformative power of entrepreneurial intelligence, the event is dedicated to promoting a culture of innovation within the medical industry. The Octane’s Medical Innovation Forum 2023 will bring together luminaries, industry veterans, and disruptive startups, to explore innovations on the edge of medical transformation. As the…

TuesdayOct 17, 2023 9:45 am

Pest Control Innovator SenesTech Inc. (NASDAQ: SNES) Offers Unique Solution to Tackle the Spread of Rats Amid Growing Health Concerns

SenesTech Inc. is building worldwide influence as a rat population control solution that humanely and cost-effectively based on fertility control The company’s trademarked ContraPest(R) brand is designed to target rat pest populations large and small, as well as hard-to-get roof rodents, and is the only EPA-registered rat contraception product for both male and female rats The rebound in rat populations worldwide in the wake of the COVID pandemic and a recent report on the spread of the rat lungworm parasite (which can sicken or kill humans) have fostered a new sense of concern about rat-carried diseases SenesTech is expanding its…

TuesdayOct 17, 2023 9:00 am

SOHM, Inc. (SHMN) Bolsters Executive Team; Confident About Anticipated Developments and Opportunities

SOHM just announced the appointment of Wm. Dewey Rushing as the new VP-Quality His appointment follows the recent nomination of Dr. Krishna Bhat as the new Chief Medical Advisor and Dr. David Aguilar as the new COO It also follows the recently signed LOI for SOHM to acquire ABBIE stem cell disruptive technology and patents from CGA Intellectual Holdings Inc. SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, is bolstering its executive team as it eyes the globalaa nutraceuticals market, which is expected to post a CAGR of 9.4% between 2023 and 2030, and the global NSAID market…

MondayOct 16, 2023 12:00 pm

PaxMedica Inc. (NASDAQ: PXMD) Announces Gold Sponsorship for The BRAIN Foundation’s Synchrony Symposia 2023

The BRAIN Foundation's Synchrony Symposia is the first and only international symposium on translational research for Autism Spectrum Disorder (“ASD”) PaxMedica Chairman and CEO Howard Weisman says that participating at the symposium is pivotal in advancing and fostering autism research As a Gold Sponsor, PaxMedica will have purview to the symposium’s interdisciplinary discussions, insights, and research presentations, clinical roundtables, mentor-mentee sessions, and more PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced its Gold Sponsorship…

MondayOct 16, 2023 11:15 am

Clene Inc. (NASDAQ: CLNN) Applies Patented Nanotechnology to Development of CNM-Au8(R), its Investigational Drug for ALS

In line with recent emphasis on the growing importance of nanotechnology in the US, Clene Nanomedicine innovated its investigational drug, CNM-Au8(R), using nanotechnology for the treatment of neurodegenerative disease Clene’s nanotechnological approach was recently recognized by the NINDS of NIH with a substantial grant to conduct an Expanded Access Protocol in ALS with CNM-Au8(R) Clene aims to file a New Drug Application for CNM-Au8(R) for ALS indications in the first half of 2024 October 2023 has turned into a month for the celebration of nanotechnology. On Wednesday, Oct. 4, 2023, three U.S.-based scientists, Moungi Bawendi, Louis Brus, and Aleksey Ekimov,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: October 2023